| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYH | Common Stock | Options Exercise | $0 | +30.2K | +0.58% | $0.00 | 5.24M | 01 Mar 2025 | Direct | F1 |
| holding | CYH | Common Stock | 1.61M | 01 Mar 2025 | by The Modified 2009 WTS Irrev Trust Dated 12/16/22 | ||||||
| holding | CYH | Common Stock | 482K | 01 Mar 2025 | WAC LLC |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYH | Performance Based Restricted | Options Exercise | $0 | -30.2K | -16.8% | $0.00 | 150K | 01 Mar 2025 | Common Stock | 30.2K | $0.00 | Direct | F1 |
| transaction | CYH | Performance Based Restricted | Disposed to Issuer | $0 | -150K | -100% | $0.00 | 0 | 01 Mar 2025 | Common Stock | 150K | $0.00 | Direct | F1 |
| transaction | CYH | Restricted Stock Units | Award | $0 | +59.8K | +26.3% | $0.00 | 287K | 01 Mar 2025 | Common Stock | 59.8K | $0.00 | Direct | F2 |
| holding | CYH | Stock Options (Right to Buy) | 78.8K | 01 Mar 2025 | Common Stock | 78.8K | $4.99 | Direct | ||||||
| holding | CYH | Stock Options (Right to Buy) | 113K | 01 Mar 2025 | Common Stock | 113K | $4.93 | Direct | ||||||
| holding | CYH | Stock Options (Right to Buy) | 90K | 01 Mar 2025 | Common Stock | 90K | $8.81 | Direct | ||||||
| holding | CYH | Stock Options (Right to Buy) | 90K | 01 Mar 2025 | Common Stock | 90K | $10.18 | Direct | ||||||
| holding | CYH | Stock Units (SU) | 35.6K | 01 Mar 2025 | Common Stock | 35.6K | $0.00 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 16.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (30,240), and the remaining 83.2% of the target number has been forfeited (149,760). |
| F2 | These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. |
| F3 | The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person. |